how to track progress on glp-1 medication KFF Semaglutide GLP-1 Symptoms & Outcomes

Continue learning Where to read next Not medical advice

Its classified as a teratogen , which means it has the potential to cause birth defects or disrupt normal fetal development if taken during pregnancy

Exercise timing and medication levels Some users report exercise-related nausea when training at peak medication levels

Endocr Rev 1999;20:876913.ArticlePubMed 78

Clinicians should be aware of this potential risk [for thyroid cancer] in initiating a GLP-1 receptor agonist and carefully monitor exposed patients, especially in the presence of other risk factors for thyroid cancer, the researchers wrote.

We need everyone thinking about nutrition therapy to make the treatment experience better, not to achieve more weight loss by driving a greater calorie deficit